reports
Man Group PLC : Form 8.3 - Smith (DS) plc
Man Group PLC : Form 8.3 - Smith (DS) plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this...
Man Group PLC : Form 8.3 - International Paper Company
Man Group PLC : Form 8.3 - International Paper Company FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant se...
MBV International Limited: 1 director
A director at MBV International Limited sold 31,400,000 shares at 0.499HKD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Kerur Holdings Ltd: 1 director
A director at Kerur Holdings Ltd bought 200,421 shares at 63.998ILS and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Man Group PLC : Form 8.3 - Mondi plc
Man Group PLC : Form 8.3 - Mondi plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form...
EQS-News: Volta Medical Announces Late-Breaking TAILORED-AF Randomized...
EQS-News: Volta Medical SAS / Key word(s): Study Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA 18.04.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA Late-Breaking Randomized Clinical Trial Data to be presented by Professor Isabel Deisenhofer, German Heart Center Munich Department of Electrophysiology Demonstration of Volta AF-...
EQS-News: Volta Medical gibt die Ergebnisse seiner randomisierten klin...
EQS-News: Volta Medical SAS / Schlagwort(e): Studie Volta Medical gibt die Ergebnisse seiner randomisierten klinischen TAILORED-AF-Studie in einer Late-Breaker Präsentation auf der Heart Rhythm 2024 in Boston, USA bekannt 18.04.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Volta Medical gibt die Ergebnisse seiner randomisierten klinischen TAILORED-AF-Studie in einer Late-Breaker Präsentation auf der Heart Rhythm 2024 in Boston, USA bekannt Late-Breaker Präsentation der Ergebnisse aus der randomisierten klinischen Studi...
Volta Medical annoncera les résultats de l’essai clinique randomisé TA...
Volta Medical SAS / Mot-clé(s) : Autres Volta Medical annoncera les résultats de l’essai clinique randomisé TAILORED-AF lors des sessions Late-Breaking du congrès Heart Rhythm 2024 à Boston, MA, États-Unis 18-Avr-2024 / 14:00 CET/CEST Volta Medical annoncera les résultats de l’essai clinique randomisé TAILORED-AF lors des sessions Late-Breaking du congrès Heart Rhythm 2024 à Boston, MA, États-Unis Les résultats « Late-Breaking » de l’essai clinique randomisé seront présentés par la Professeure Isabel Deisenhofer, du Département d’Electrophysiologie du Centre Allemand de Cardi...
EQS-News: SNP übernimmt Trigon Consulting und stärkt Premiumservices f...
EQS-News: SNP Schneider-Neureither & Partner SE / Schlagwort(e): Firmenübernahme SNP übernimmt Trigon Consulting und stärkt Premiumservices für Kunden und Partner 18.04.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Corporate News SNP übernimmt Trigon Consulting und stärkt Premiumservices für Kunden und Partner Beratungsspezialist für IT- und Business-Transformationen, Datenmigration und Digitalisierung wird mit Wirkung zum 1. Mai 2024 Teil der SNP-Gruppe Erweiterung und Stärkung des SNP-Kooperationsmodells, das Partn...
EQS-News: SNP acquires Trigon Consulting and strengthens premium servi...
EQS-News: SNP Schneider-Neureither & Partner SE / Key word(s): Takeover SNP acquires Trigon Consulting and strengthens premium services for customers and partners 18.04.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Corporate News SNP acquires Trigon Consulting and strengthens premium services for customers and partners Consulting specialist for IT and business transformations, data migration and digitalization joins the SNP Group with effect from May 1, 2024 The move expands and strengthens the SNP go-to-market model, enab...
Lexicon Pharmaceuticals to Host 2024 Investor Day
Lexicon Pharmaceuticals to Host 2024 Investor Day Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic Pain THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a.m. to 12:00 p.m. ET. Business and scientific updates will be presented by Lonnel Coats, Lexicon’s c...
Allegro MicroSystems to Announce Fourth Quarter and Fiscal Year 2024 F...
Allegro MicroSystems to Announce Fourth Quarter and Fiscal Year 2024 Financial Results MANCHESTER, N.H., April 18, 2024 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced it plans to release financial results for its fourth quarter and fiscal year 2024 prior to the market open on Thursday, May 9, 2024. Following the press release, Vineet Nargolwala, President and Chief Executive Officer, and Derek D’Antilio, Senior Vice President and Chief Financial Officer, will host a conference call at 8:30 a.m. Eastern Time to discuss the Company’s results and business outlo...
TransUnion Promotes Ashish Khattar to Chief Revenue Officer of Canada
TransUnion Promotes Ashish Khattar to Chief Revenue Officer of Canada A seasoned sales executive with significant experience in financial services and information solutions, Khattar will be responsible for continuing TransUnion’s strong growth in Canada. TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- TransUnion (NYSE:TRU) has promoted Ashish Khattar to Chief Revenue Officer of Canada. With a successful track record and extensive financial services and information solutions experience, Khattar will oversee sales, customer success, sales operations and enablement for TransUnion’s Canada busi...
Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Founda...
Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation Proceeds Will Help Protect Oceans, Waves and Beaches for All People to Enjoy MONTAUK, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- (“Montauk Brewing” or “Montauk”), the leading and fastest-selling craft brewer in Metro New York known for its exceptional craft beers and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced the return of Project 4:20 India Pale Ale, a limited release crafted to celebrate and support green charities during Earth Month and beyond. This year, Montauk will dona...
AGBA and Triller Merge to Create a $4 Billion Powerhouse, Unleashing a...
AGBA and Triller Merge to Create a $4 Billion Powerhouse, Unleashing a Game-Changing Power in Digital Content and Financial Services Transaction expected to value the combination of AGBA and Triller at approximately $4 billion.Majority shareholder support already obtained from both AGBA and Triller.At closing, Triller will be a wholly-owned subsidiary of AGBA.AGBA stockholders will own 20% of the combined company, while Triller stockholders will own the remaining 80% of the combined company. LOS ANGELES, April 18, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited...
Westwood Holdings Group, Inc. to Host First Quarter 2024 Conference Ca...
Westwood Holdings Group, Inc. to Host First Quarter 2024 Conference Call/Webcast DALLAS, April 18, 2024 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its first quarter 2024 earnings after the close of the New York Stock Exchange on Wednesday, May 1, 2024. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time). To join the conference call, please register here: . After registering, you will be provided with a dial-in number containing a personalized PIN. Webcast Link: ...
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 &...
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024 LANGHORNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will be presenting at the Planet MicroCap Showcase: VEGAS 2024, taking place at the Paris Hotel and Casino, Las Vegas, NV on May 1st and 2nd. Planet MicroCap Showcase: VEGAS 2024 ...
WillScot Mobile Mini to Announce First Quarter 2024 Results on May 2, ...
WillScot Mobile Mini to Announce First Quarter 2024 Results on May 2, 2024 PHOENIX, April 18, 2024 (GLOBE NEWSWIRE) -- WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that it will release its first quarter 2024 financial results on May 2, 2024, after market close. Chief Executive Officer, Brad Soultz, and President and Chief Financial Officer, Tim Boswell, will host a conference call and webcast on May 2, 2024, at 5:30 p.m. ET to discuss the Company’s results. To access the liv...
Infinera GX Series Powers Paratus Superhighway Network Between Johanne...
Infinera GX Series Powers Paratus Superhighway Network Between Johannesburg and Europe SAN JOSE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Infinera (Nasdaq: INFN) announced today that Paratus Group, a leading network provider in Africa, deployed Infinera’s and FlexILS solutions to offer the lowest-latency express route between Johannesburg and Lisbon, delivering services with a latency of 123 milliseconds and supporting wavelengths up to 800G. Infinera’s solutions were deployed on the recently completed 1,890-km Paratus express fiber link between Johannesburg and Europe, via Botswana to...
Provectus Biopharmaceuticals Announces Publication of Preclinical Data...
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers Research on breast, colorectal, head and neck, and testicular cancersNovel downregulation of WNK1 and Wnt signaling KNOXVILLE, TN, April 18, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from preclinical research by the University of Calgary on oral administration of Provectus’s pharmaceutical-grade rose bengal for the treatments of solid tumor cancers were publis...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.